270 related articles for article (PubMed ID: 27329556)
1. Blockade of uptake for dopamine, but not norepinephrine or 5-HT, increases selection of high effort instrumental activity: Implications for treatment of effort-related motivational symptoms in psychopathology.
Yohn SE; Errante EE; Rosenbloom-Snow A; Somerville M; Rowland M; Tokarski K; Zafar N; Correa M; Salamone JD
Neuropharmacology; 2016 Oct; 109():270-280. PubMed ID: 27329556
[TBL] [Abstract][Full Text] [Related]
2. Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms.
Randall PA; Lee CA; Podurgiel SJ; Hart E; Yohn SE; Jones M; Rowland M; López-Cruz L; Correa M; Salamone JD
Int J Neuropsychopharmacol; 2014 Oct; 18(2):. PubMed ID: 25575584
[TBL] [Abstract][Full Text] [Related]
3. The monoamine-oxidase B inhibitor deprenyl increases selection of high-effort activity in rats tested on a progressive ratio/chow feeding choice procedure: Implications for treating motivational dysfunctions.
Yohn SE; Reynolds S; Tripodi G; Correa M; Salamone JD
Behav Brain Res; 2018 Apr; 342():27-34. PubMed ID: 29292157
[TBL] [Abstract][Full Text] [Related]
4. Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding.
Rotolo RA; Kalaba P; Dragacevic V; Presby RE; Neri J; Robertson E; Yang JH; Correa M; Bakulev V; Volkova NN; Pifl C; Lubec G; Salamone JD
Psychopharmacology (Berl); 2020 Nov; 237(11):3459-3470. PubMed ID: 32770257
[TBL] [Abstract][Full Text] [Related]
5. Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.
Nunes EJ; Randall PA; Hart EE; Freeland C; Yohn SE; Baqi Y; Müller CE; López-Cruz L; Correa M; Salamone JD
J Neurosci; 2013 Dec; 33(49):19120-30. PubMed ID: 24305809
[TBL] [Abstract][Full Text] [Related]
6. Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat.
Yohn SE; Lopez-Cruz L; Hutson PH; Correa M; Salamone JD
Psychopharmacology (Berl); 2016 Mar; 233(6):949-60. PubMed ID: 26694811
[TBL] [Abstract][Full Text] [Related]
7. The novel atypical dopamine transport inhibitor CT-005404 has pro-motivational effects in neurochemical and inflammatory models of effort-based dysfunctions related to psychopathology.
Rotolo RA; Presby RE; Tracy O; Asar S; Yang JH; Correa M; Murray F; Salamone JD
Neuropharmacology; 2021 Feb; 183():108325. PubMed ID: 32956676
[TBL] [Abstract][Full Text] [Related]
8. The dopamine reuptake inhibitor MRZ-9547 increases progressive ratio responding in rats.
Sommer S; Danysz W; Russ H; Valastro B; Flik G; Hauber W
Int J Neuropsychopharmacol; 2014 Dec; 17(12):2045-56. PubMed ID: 24964269
[TBL] [Abstract][Full Text] [Related]
9. The dopamine depleting agent tetrabenazine alters effort-related decision making as assessed by mouse touchscreen procedures.
Yang JH; Presby RE; Rotolo RA; Quiles T; Okifo K; Zorda E; Fitch RH; Correa M; Salamone JD
Psychopharmacology (Berl); 2020 Sep; 237(9):2845-2854. PubMed ID: 32561947
[TBL] [Abstract][Full Text] [Related]
10. Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization.
Yohn SE; Arif Y; Haley A; Tripodi G; Baqi Y; Müller CE; Miguel NS; Correa M; Salamone JD
Psychopharmacology (Berl); 2016 Oct; 233(19-20):3575-86. PubMed ID: 27497935
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in lever pressing and running wheel tasks of effort-based choice behavior in rats: Suppression of high effort activity by the serotonin transport inhibitor fluoxetine.
Presby RE; Rotolo RA; Hurley EM; Ferrigno SM; Murphy CE; McMullen HP; Desai PA; Zorda EM; Kuperwasser FB; Carratala-Ros C; Correa M; Salamone JD
Pharmacol Biochem Behav; 2021 Mar; 202():173115. PubMed ID: 33493546
[TBL] [Abstract][Full Text] [Related]
12. Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior.
Yohn SE; Collins SL; Contreras-Mora HM; Errante EL; Rowland MA; Correa M; Salamone JD
Neuropsychopharmacology; 2016 Feb; 41(3):686-94. PubMed ID: 26105139
[TBL] [Abstract][Full Text] [Related]
13. The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs.
Randall PA; Lee CA; Nunes EJ; Yohn SE; Nowak V; Khan B; Shah P; Pandit S; Vemuri VK; Makriyannis A; Baqi Y; Müller CE; Correa M; Salamone JD
PLoS One; 2014; 9(6):e99320. PubMed ID: 24937131
[TBL] [Abstract][Full Text] [Related]
14. Effects of the triple monoamine uptake inhibitor amitifadine on pain-related depression of behavior and mesolimbic dopamine release in rats.
Miller LL; Leitl MD; Banks ML; Blough BE; Negus SS
Pain; 2015 Jan; 156(1):175-184. PubMed ID: 25599313
[TBL] [Abstract][Full Text] [Related]
15. Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats.
Baarendse PJ; Vanderschuren LJ
Psychopharmacology (Berl); 2012 Jan; 219(2):313-26. PubMed ID: 22134476
[TBL] [Abstract][Full Text] [Related]
16. Triple reuptake inhibition of serotonin, norepinephrine, and dopamine increases the tonic activation of α
Jiang JL; El Mansari M; Blier P
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Dec; 103():109987. PubMed ID: 32474007
[TBL] [Abstract][Full Text] [Related]
17. Adenosine A(2A) receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing.
Farrar AM; Pereira M; Velasco F; Hockemeyer J; Müller CE; Salamone JD
Psychopharmacology (Berl); 2007 Apr; 191(3):579-86. PubMed ID: 17072593
[TBL] [Abstract][Full Text] [Related]
18. Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates.
Hansard MJ; Smith LA; Jackson MJ; Cheetham SC; Jenner P
J Pharmacol Exp Ther; 2002 Dec; 303(3):952-8. PubMed ID: 12438514
[TBL] [Abstract][Full Text] [Related]
19. Differential modulation of efficiency in a food-rewarded "differential reinforcement of low-rate" 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitors.
Dekeyne A; Gobert A; Auclair A; Girardon S; Millan MJ
Psychopharmacology (Berl); 2002 Jul; 162(2):156-67. PubMed ID: 12110993
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters.
Dutta AK; Santra S; Sharma H; Voshavar C; Xu L; Mabrouk O; Antonio T; Reith ME
PLoS One; 2014; 9(11):e113420. PubMed ID: 25427177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
